|
1 Shannon–Lowe C, Baldwin G, Feederle R, et al. Epstein–Barr virus–induced B–cell transformation: Quantitating events from virus binding to cell outgrowth. J General Virol, 2005, 86(Pt 11): 3009–3019.
|
|
2 Paul GA. Recent advance in the understanding of infectious mononucleosis: Are prospects improved for treatment or control? Exp Rev Anti Infect Ther, 2006, 4(6): 1039–1049.
|
|
3 Hjalgrim H, Smedby KE, Rostgaard K, et al. Infectious mononucleosis, childhood social environment, and risk of Hodgkin lymphoma. Cancer Res, 2007, 67(5): 2382–2388.
|
|
4 Tao Q, Young LS, Woodman CB, et al. Epstein–Barr virus (EBV) and its associated human cancers——Genetics, epigenetics, pathobiology and novel therapeutics. Front Biosci, 2006, 11: 2672–2713.
|
|
5 Hu YM, Jiang ZF, ed. Zhu Futang textbook of pediatrics. 7th ed. Beijing: People's Medical Publishing House, 2003, 821–827.[胡亚美，江载芳，主编. 诸福棠实用儿科学. 7版. 北京：人民卫生出版社，2003, 821–827.]
|
|
6 Lindsley RC, Thomas M, Srivastava B, et al. Generation of peripheral B cells occurs via two spatially and temporally distinct pathways. Blood, 2007, 109(6): 2521–2528.
|
|
7 Kasprzak A, Spachacz R, Halon A, et al. Tissue markers of Epstein–Bar virus (EBV) infection in B–cell non–Hodgkin's lymphomas. Med Wieku Rozwoj, 2006, 10(3 Pt 1): 639–648.
|
|
8 Klein E, Kis LL, klein G. Epstein–Barr virus infection in humans: From harmless to life endangering virus–lymphocyte interactions. Oncogene, 2007, 26(9): 1297–1305.
|
|
9 Hislop AD, Taylor GS, Sauce D, et al. Cellular responses to viral infection in humans: Lessons from Epstein–Barr virus. Annu Rev Immunol, 2007, 25: 587–617.
|
|
10 Sandalova E, Hislop AD, Levitsky V. T–cell receptor triggering differentially regulates bim expression in human lymphocytes from healthy individuals and patients with infectious mononucleosis. Hum Immunol, 2006, 67(12): 958–965.
|
|
11 Adhikary D, Behrends U, Moosmann A, et al. Control of Epstein–Barr virus infection in vitro by T helper cells specific for virion glycoproteins. J Exp Med, 2006, 203(4): 995–1006.
|
|
12 Piriou ER, van Dort K, Weel JF, et al. Detailed kinetics of EBV–specific CD4＋ and CD8＋ T cells during primary EBV infection in a kidney transplant patient. Clin Immunol, 2006, 119(1): 16–20.
|
|
13 Scherrenburg J, Piriou ER, Nanlohy NM, et al. Detailed analysis of Epstein–Barr virus–specific CD4＋ and CD8＋ T cell responses during infectious mononucleosis. Clin Exp Immunol, 2008, 153(2): 231–239.
|
|
14 Long HM, Haigh TA, Gudgeon NH, et al. CD4＋ T–cell responses to Epstein–Barr virus (EBV) latent–cycle antigens and the recognition of EBV–transformed lymphoblastoid cell lines. J Virol, 2005, 79(8): 4896–4907.
|